VISIPAQUE INJECTION 270 mgI/ml
Product details
Registration number: SIN08882P
Classification: Prescription Only
Active ingredients: IODIXANOL EQV IODINE
Strength: 270 mgI/ml
Dosage form: INJECTION
Route: INTRAVENOUS; INTRA-ARTERIAL; INTRATHECAL
Registrant: GE HEALTHCARE PTE. LTD.
ATC code: V08AB09
HSA approval date: 28 August 1996
Manufacturer(s):
- GE HEALTHCARE IRELAND LIMITED (by Parametric Release)
- GE HEALTHCARE AS (by Parametric Release)
- GE HEALTHCARE (SHANGHAI) CO., LTD
Manufacturing country/countries: IRELAND; NORWAY; CHINA
What are the HSA registration number and classification for VISIPAQUE INJECTION 270 mgI/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN08882P
Classification: Prescription Only
What active ingredients and strength are recorded for VISIPAQUE INJECTION 270 mgI/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: IODIXANOL EQV IODINE
Strength: 270 mgI/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for VISIPAQUE INJECTION 270 mgI/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAVENOUS; INTRA-ARTERIAL; INTRATHECAL
Who is the recorded registrant for VISIPAQUE INJECTION 270 mgI/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: GE HEALTHCARE PTE. LTD.
Which manufacturers and countries are listed for VISIPAQUE INJECTION 270 mgI/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- GE HEALTHCARE IRELAND LIMITED (by Parametric Release)
- GE HEALTHCARE AS (by Parametric Release)
- GE HEALTHCARE (SHANGHAI) CO., LTD
Manufacturing country/countries: IRELAND; NORWAY; CHINA
Where can I look up VISIPAQUE INJECTION 270 mgI/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN08882P or the exact product name VISIPAQUE INJECTION 270 mgI/ml. The general register link does not preselect this product.
What are the source dates for this VISIPAQUE INJECTION 270 mgI/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this VISIPAQUE INJECTION 270 mgI/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN08882P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)